Mostrar el registro sencillo del ítem

dc.contributor.authorPinzón Amado, Alexánderspa
dc.date.accessioned2020-10-27T14:22:40Z
dc.date.available2020-10-27T14:22:40Z
dc.date.issued2001-09-10
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10579
dc.description.abstractLos anticonvulsivantes valproato y carbamazepina han mostrado eficacia en el tratamiento del trastorno bipolar(TB). El anticonvulsivante de segunda generación lamotrigina ha sido reportado como un medicamento que posee efectos antimaníaco, antidepresivo y modulador afectivo. Se han publicado hasta la fecha diversos reportes y series de casos, estudios abiertos y dos ensayos clínicos controlados sobre el uso de la lamotrigina en el TB. La inhibición de los canales de sodio voltaje sensibles, la inhibición en la secreción degluta mato y el bloqueo de los canales de calcio se han propuesto como posibles mecanismos de acción de la lamotrigina para explicar su efecto en la modulación afectiva. El presente artículo revisará los conceptos actuales acerca de la eficacia de la lamotrigina en el tratamiento del TBspa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/314/296
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/314
dc.rights.urihttps://gol.caracoltv.com/partidos
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 4 Núm. 11 (2001): Leucoria, Ensayos clínicos, Mortalidad neonatal; 107-113
dc.subjectCiencias biomédicas
dc.subjectCiencias de la vida
dc.subjectInnovaciones en salud
dc.subjectInvestigaciones
dc.titleLamotrigina: evidencia de su utilidad en el trastorno bipolarspa
dc.title.translatedLamotrigine: evidence of its usefulness in bipolar disordereng
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programPregrado Medicinaspa
dc.type.driverinfo:eu-repo/semantics/article
dc.type.localArtículospa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.subject.keywordsHealth Scienceseng
dc.subject.keywordsMedicineeng
dc.subject.keywordsMedical Scienceseng
dc.subject.keywordsBiomedical Scienceseng
dc.subject.keywordsLife Scienceseng
dc.subject.keywordsInnovations in healtheng
dc.subject.keywordsResearcheng
dc.subject.keywordsLamotrigineeng
dc.subject.keywordsAnticonvulsantseng
dc.subject.keywordsBipolar disordereng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.type.hasversionInfo:eu-repo/semantics/publishedVersion
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.referencesGoodwin FK, Jamison KR. Manic Depressive Illness. New York,NY: Oxford University Press; 1990spa
dc.relation.referencesAmerican Psychiatric Association. Diagnostic and statisticalmanual of mental disorders. 4th ed. Washington (DC): 1994spa
dc.relation.referencesSolomon D, Keitner G, Miller I, Shea T, Keller M. Course ofillness and maintenance treatments options for patients withbipolar disorder. J Clin Psychiatry 1995; 56 (1): 5-13spa
dc.relation.referencesSimpson S, Jamison K. The risk of suicide in patients withbipolar disorders. J Clin Psychiatry 1999; 60 (Suppl 2): 53-6spa
dc.relation.referencesHarris C, Barraclough B. Suicide as an outcome for mentaldisorders: a meta-analysis. Br J Psychiatry 1997; 170: 205-28spa
dc.relation.referencesGoldberg J, Harrow M. Poor-outcome bipolar disorders. En Bipolardisorders: Clinical course and outcome, Goldberg J, Harrow M.Editors, American Psychiatric Press, Washington D.C., 1999spa
dc.relation.referencesWoods S. The economic burden of bipolar disease. J ClinPsychiatry 2000; 61 (Suppl 13): 38-41.spa
dc.relation.referencesCalabrese J, Bowden C, Woyshville M. Lithium and theanticonvulsants in the treatment of bipolar disorder. EnPsychopharmacology: The Fourth Generation of Progress,Blomm F. and Kupfer D. Editors, Raven Press, New York, 1995spa
dc.relation.referencesWork Group on Bipolar Disorder. Practice guideline for treatmentof patients with bipolar disorder. In American PsychiatricAssociation Practice Guidelines. American Psychiatric Press,Washington D.C., 1996spa
dc.relation.referencesCalabrese J, Woyshwille M. Lithium therapy: Limitations andalternatives in the treatment of bipolar disorders. Ann ClinPsychiatr 1995; 7 (2): 103-12spa
dc.contributor.cvlacPinzón Amado, Alexánder [0000328758]spa
dc.contributor.googlescholarPinzón Amado, Alexánder [cdDLVRQAAAAJ&hl=es&oi=ao]spa
dc.contributor.orcidPinzón Amado, Alexánder [0000-0002-4369-9603]spa
dc.subject.lembCiencias de la saludspa
dc.subject.lembCiencias médicasspa
dc.subject.lembMedicinaspa
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.description.abstractenglishThe anticonvulsants valproate and carbamazepine have shown efficacy in the treatment of bipolar disorder (TB). The second-generation anticonvulsant lamotrigine has been reported as a medication that has antimanic, antidepressant, and affective modulating effects. To date, various reports and case series, open studies and two controlled clinical trials have been published on the use of lamotrigine in TB. Inhibition of voltage-sensitive sodium channels, inhibition of swallowing secretion and blockade of calcium channels have been proposed as possible mechanisms of action of lamotrigine to explain its effect on affective modulation. This article will review current concepts about the effectiveness of lamotrigine in the treatment of TB.eng
dc.subject.proposalLamotriginaspa
dc.subject.proposalAnticonvulsivantesspa
dc.subject.proposalTrastorno bipolarspa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem